Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Epinephrine Formulation and Fill-Finish Manufacturing

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract through DLA Troop Support involves the formulation and fill-finish manufacturing of Epinephrine 0.3 MG/0.3 ML solution for prime contractors on Department of Defense pharmaceutical contracts. The scope of work encompasses the chemical synthesis or sourcing of the active pharmaceutical ingredient, the formulation of the injection solution, and the sterile filling of auto-injector devices utilizing automated fill-finish lines and sterile cleanrooms. To qualify for this engagement, the manufacturer must maintain facility cGMP certification and hold FDA approval via a New Drug Application or Abbreviated New Drug Application. The final deliverable consists of filled and sealed Epinephrine auto-injectors. The solicitation was posted on October 1, 2026, with a response deadline of November 2, 2026, under NAICS code 325412.

General Info

cGMP manufacturer to produce and fill Epinephrine auto-injectors for DLA Troop Support.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PA

Set-Aside

NONE

Documents

This scope was carved out of SPE2D2-26-R-0009.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

PHARM MANUF/DISTR DIV - FSA

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures Epinephrine 0.3 MG/0.3 ML solution for prime contractors on DoD pharmaceutical contracts. Performs chemical synthesis or sourcing of API, formulation of injection solution, and sterile filling into auto-injector devices using sterile cleanrooms and automated fill-finish lines. Requires FDA approval via NDA or ANDA and facility cGMP certification. Delivers filled and sealed Epinephrine auto-injectors.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79727R0039 for Latanoprost Ophthalmic Solution. This acquisition aims to establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The procurement is issued in commercial item format per FAR Part 12 under NAICS code 325412 and is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Strict labeling requirements are in place, requiring offerors to provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the sole label on the product, cannot be affixed over another label, and must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. The solicitation is expected to be issued around October 21, 2026, with a tentative closing date of November 4, 2026, though some metadata indicates a response deadline of October 16, 2026.
Nac Pharmaceuticals (36E797)

POSTED

about 22 hours ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS